About AST

Transplant News

June, 2013

June 05, 2013
AST/Novartis Basic Science Faculty Development Grant Dr. Jamil Azzi Research Title: The Novel Role of P13Ky Pathway in Alloimmunity and Tolerance Dr. Azzi is an instructor in medicine from Brigham and Women’s Hospital. He is particularly interested in achieving allograft tolerance, and developed an early interest in exploring innovative and safer immunosuppressive strategies. His previous research experiences lead him to conclude that finding tolerogenic strategies relies on targeting key players in the survival of memory and regulatory cells. Dr. Azzi’s goal is to improve patient care as an... Read More...

May, 2013

May 31, 2013
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies NCBI In the United States, more than 2600 kidneys are discarded annually, from the total number of kidneys procured for transplant. It has been hypothesized that this organ pool may be used as a platform for renal bioengineering and regeneration research. The purpose of the current study was to test if the same strategy can be applied to discarded human kidneys in order to obtain human renal ECM scaffolds. The results show that the sodium dodecylsulfate-based decellularization protocol completely... Read More...
May 31, 2013
We're pleased to now offer AST-branded apparel, exclusively from the AST Store! Pick up one of our new fleece jackets, polo shirts or baseball caps, embroidered with the AST logo. Items start at just $20!  
May 31, 2013
Are you interested in receiving recognition and increased exposure for your transplant center? Does you center support the future of transplantation and value the educational, networking and research opportunities that the American Society of Transplantation (AST) provides to its members? Does your center support AST's lobbying of the U.S. Congress and Federal Agencies to secure a more transplant provided friendly environment for patients and physicians? If the answer to these questions is YES, please consider having your center participate in AST's Institutional Support Program. With a... Read More...
May 28, 2013
Effective May 20, 2013, Robert W. Walsh has been appointed as the Director of HRSA's Division of Transplantation (DoT). Bob has worked within the DoT for approximately five years, most recently as the Project Officer for the Organ Procurement and Transplantation Network (OPTN) contract. In that capacity, he also served as an ex offivio member of the OPTN Board of Directors and numerous committees. Prior to joining HRSA, Bob worked at the American Psychological Association in Washington, DC. There, he served in several capacities including the Associate Executive Director for Governance. Bob... Read More...
May 24, 2013
4 key issues in facial allotransplantation By Maria Frisch Facial allotransplantation has transformed the future of patients with severe facial disfigurement by allowing for nearly normal facial restoration. Since 2005, at least 21 facial allotransplantations have been performed worldwide, with an estimated 90 percent overall success rate — two of the 21 patients died. This article summarizes four key issues regarding this procedure. Read more.  Liver... Read More...
May 24, 2013
The AST is only as strong as our members, so we are asking for your help in supporting the AST Endowment if you have not already done so this year. The Endowment Fund has made it possible for the society to subsidize programs that are core to our mission, such as funding for research grants and education for the next generation of transplant professionals at our annual fellows symposium. In a time when funding from external sources is declining, any contribution, great or small, is very much appreciated. And you can be confident that 100... Read More...
May 24, 2013
Nearly 4,000 transplant professionals from around the world came together at this year's American Transplant Congress in Seattle. Between the 600 exhibitors and 1,776 oral and poster presenters, attendees enjoyed networking events, sunrise symposia, COP meetings and events and opportunities to connect with the AST colleagues. The AST also acknowledged the AST Achievement Award winners, grant recipients and Lifetime Achievement Award winner, Dr. Roy First, while Immediate Past President Dr. Roz... Read More...
May 21, 2013
The field of organ transplantation is currently experiencing a severe decline in therapeutic and device innovation. Although previous investments in transplant research have saved and improved countless lives, the medical science behind the gift-of-life has entered a period where it may lose its edge if pharmaceutical and device development strategies are not encouraged. AST has been meeting with officials within the U.S. Food and Drug Administration (FDA) Office of Medical Policy, Division of Transplantation and the Center for Drug Evaluation and Research to identify and discuss some of... Read More...
May 13, 2013
The AST is only as strong as our members, so we are asking for your help in supporting the AST Endowment if you have not already done so this year. The Endowment Fund has made it possible for the society to subsidize programs that are core to our mission, such as funding for research grants and education for the next generation of transplant professionals at our annual fellows symposium. In a time when funding from external sources is declining, any contribution, great or small, is very much appreciated. And you can be confident that 100... Read More...

Pages